Literature DB >> 2208113

Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow.

B Berling1, F Kolbinger, F Grunert, J A Thompson, F Brombacher, F Buchegger, S von Kleist, W Zimmermann.   

Abstract

The carcinoembryonic antigen (CEA) gene family belongs to the immunoglobulin superfamily and can be subdivided into the CEA and pregnancy-specific glycoprotein subgroups. The basic structure of the encoded proteins consists of, in addition to a leader, one IgV-like and 2, 3, or 6 IgC-like domains. These domains are followed by varying COOH-terminal regions responsible for secretion, transmembrane anchoring, or insertion into the membrane by a glycosyl phosphatidylinositol tail. Here we report on the characterization of CGM6, a new member of the CEA gene subgroup, by complementary DNA cloning. The deduced coding region comprises 349 amino acids and consists of a leader, one IgV-like, two IgC-like domains, and a hydrophobic region, which is replaced by a glycosyl phosphatidylinositol moiety in the mature protein. CGM6 transcripts were only found thus far in leukocytes of chronic myeloid leukemia patients, in normal bone marrow, and in marginal amounts in normal granulocytes. The CGM6 gene product might, therefore, represent a myeloid marker. Analyses of CGM6 protein-expressing HeLa transfectants with monoclonal antibodies strongly indicate that the CGM6 gene codes for the CEA family member NCA-95.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208113

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Finding unexpected patterns in microarray data.

Authors:  Susana Perelman; María Agustina Mazzella; Jorge Muschietti; Tong Zhu; Jorge J Casal
Journal:  Plant Physiol       Date:  2003-12       Impact factor: 8.340

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  Assembly and analysis of cosmid contigs in the CEA-gene family region of human chromosome 19.

Authors:  K Tynan; A Olsen; B Trask; P de Jong; J Thompson; W Zimmermann; A Carrano; H Mohrenweiser
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  Role of nonspecific cross-reacting antigen, a CD66 cluster antigen, in activation of human granulocytes.

Authors:  M L Klein; S A McGhee; J Baranian; L Stevens; S A Hefta
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes.

Authors:  S D Gray-Owen; C Dehio; A Haude; F Grunert; T F Meyer
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose.

Authors:  H G Leusch; Z Drzeniek; Z Markos-Pusztai; C Wagener
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

7.  Differential recognition of members of the carcinoembryonic antigen family by Opa variants of Neisseria gonorrhoeae.

Authors:  M P Bos; F Grunert; R J Belland
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Engulfment of Neisseria gonorrhoeae: revealing distinct processes of bacterial entry by individual carcinoembryonic antigen-related cellular adhesion molecule family receptors.

Authors:  Shannon E McCaw; Edward H Liao; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  CD66 receptor specificity exhibited by neisserial Opa variants is controlled by protein determinants in CD66 N-domains.

Authors:  M P Bos; M Kuroki; A Krop-Watorek; D Hogan; R J Belland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 10.  Circulating tumour markers in breast cancer.

Authors:  Ettore Seregni; Antonio Coli; Nicola Mazzucca
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.